共 55 条
[1]
Cioroianu A.I., Stinga P.I., Sticlaru L., Et al., Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis, Analytical Cellular Pathology, 2019, pp. 8586354-8586359, (2019)
[2]
Stegemann M., Denker S., Schmitt C.A., DLBCL 1L-What to Expect beyond R-CHOP?, Cancers, 14, 6, (2022)
[3]
Frontzek F., Karsten I., Schmitz N., Lenz G., Current Options and Future Perspectives in the Treatment of Patients With Relapsed/refractory Diffuse Large B-Cell Lymphoma, Ther Adv Hematol, 13, (2022)
[4]
Zhang M., Yu J., Zheng R., [Research Progress of Ferroptosis in Sepsis], Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 34, 9, pp. 985-990, (2022)
[5]
Wang H., Liu C., Zhao Y., Gao G., Mitochondria Regulation in Ferroptosis, European Journal of Cell Biology, 99, 1, (2020)
[6]
Yu H., Guo P., Xie X., Wang Y., Chen G., Ferroptosis, a New Form of Cell Death, and its Relationships With Tumourous Diseases, Journal of Cellular and Molecular Medicine, 21, 4, pp. 648-657, (2017)
[7]
Liu P., Wang W., Li Z., Et al., Ferroptosis: A New Regulatory Mechanism in Osteoporosis, Oxidative Medicine and Cellular Longevity, 2022, (2022)
[8]
Liu P., Feng Y., Li H., Et al., Ferrostatin-1 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting Ferroptosis, Cellular & Molecular Biology Letters, 25, 1, (2020)
[9]
Wu X., Li Y., Zhang S., Zhou X., Ferroptosis as a Novel Therapeutic Target for Cardiovascular Disease, Theranostics, 11, 7, pp. 3052-3059, (2021)
[10]
Fearnhead H.O., Vandenabeele P., Vanden Berghe T., How Do We Fit Ferroptosis in the Family of Regulated Cell Death?, Cell Death & Differentiation, 24, 12, pp. 1991-1998, (2017)